Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders)
  4. Volume 25, Issue 2
  5. Article
Volume 25, Issue 2
  • ISSN: 1871-5265
  • E-ISSN: 2212-3989

Abstract

Background

Iran has a relatively high prevalence of , which correlates with high-risk areas for gastric cancer worldwide.

Methods

Our study aimed to investigate the underlying genetic mechanisms associated with resistance to metronidazole (frxA, rdxA), clarithromycin (23S rRNA), tetracycline (16S rRNA), and fluoroquinolone (gyrA) in -positive dyspeptic patients using PCR and sequencing. We further examined the potential correlation between resistance profiles and various virulence genotypes.

Results

The rates of genetic mutations associated with resistance to metronidazole, fluoroquinolone, clarithromycin, and tetracycline were found to be 68%, 32.1%, 28.4%, and 11.1%, respectively. Well-documented multiple antibiotic resistance mutations were detected, such as rdxA and frxA (with missense and frameshift alterations), gyrA (Asp91, Asn87), 23S rRNA (A2142G, A2143G), and 16S rRNA (triple-base-pair substitutions AGA926-928→TTC). The cagA+ and vacA s1/m1 types were the predominant genotypes in our study. With the exception of metronidazole and tetracycline, no significant correlation was observed between the cagA+ and cagL+ genotypes and resistance-associated mutations.

Conclusion

The prevalence of antibiotic resistance-associated mutations in was remarkably high in this region, particularly to metronidazole, ciprofloxacin, and clarithromycin. By conducting a simultaneous screening of virulence and resistance genotypes, clinicians can make informed decisions regarding the appropriate therapeutic regimen to prevent the escalation of antibiotic resistance against infection in this specific geographical location.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/iddt/10.2174/0118715265294927240617201332
2024-07-09
2025-01-01

  • From This Site

    /content/journals/iddt/10.2174/0118715265294927240617201332
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. CalvetX. Ramírez LázaroMJ Lehours P Mégraud F. Diagnosis and epidemiology of Helicobacter pylori infection.Helicobacter201318s1Suppl. 151110.1111/hel.12071 24011238
     [Google Scholar]
  2. de MartelC. GeorgesD. BrayF. FerlayJ. CliffordG.M. Global burden of cancer attributable to infections in 2018: A worldwide incidence analysis.Lancet Glob. Health202082e180e19010.1016/S2214‑109X(19)30488‑7 31862245
     [Google Scholar]
  3. FerlayJ. ColombetM. SoerjomataramI. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.Int. J. Cancer201914481941195310.1002/ijc.31937 30350310
     [Google Scholar]
  4. RoohinejadZ. BahramianS. ShamsabadiF.T. Upregulation of the c-MYC oncogene and adjacent long noncoding RNAs PVT1 and CCAT1 in esophageal squamous cell carcinoma.BMC Cancer20232313410.1186/s12885‑022‑10464‑z 36624401
     [Google Scholar]
  5. BrayF. FerlayJ. SoerjomataramI. SiegelR.L. TorreL.A. JemalA. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J. Clin.201868639442410.3322/caac.21492 30207593
     [Google Scholar]
  6. FakheriH. Saberi FirooziM. BariZ. Eradication of Helicobacter pylori in Iran: A Review.Middle East J. Dig. Dis.201710151710.15171/mejdd.2017.84 29682242
     [Google Scholar]
  7. FalloneC.A. MossS.F. MalfertheinerP. Reconciliation of recent Helicobacter pylori treatment guidelines in a time of increasing resistance to antibiotics.Gastroenterology20191571445310.1053/j.gastro.2019.04.011 30998990
     [Google Scholar]
  8. SholehM. MalekiF. KrutovaM. The increasing antimicrobial resistance of Helicobacter pylori in Iran: A systematic review and meta‐analysis.Helicobacter2020255e1273010.1111/hel.12730 32705749
     [Google Scholar]
  9. SalehiR. MohajeriP. Study of vac A genotypes of H. pylori isolated from patients with the upper gastrointestinal diseases by PCR.J Isfahan Med Sch2015172935
     [Google Scholar]
  10. BassoD. ZambonC.F. LetleyD.P. Clinical Relevance of Helicobacter pylori cagA and vacA Gene Polymorphisms.Gastroenterology20081351919910.1053/j.gastro.2008.03.041 18474244
     [Google Scholar]
  11. DundonW.G. BernardM. MontecuccoC. Virulence factors of Helicobacter pylori.Int. J. Med. Microbiol.2001290864765810.1016/S1438‑4221(01)80002‑3 11310443
     [Google Scholar]
  12. OguraK. MaedaS. NakaoM. Virulence factors of Helicobacter pylori responsible for gastric diseases in Mongolian gerbil.J. Exp. Med.2000192111601161010.1084/jem.192.11.1601 11104802
     [Google Scholar]
  13. UotaniT. GrahamD.Y. Diagnosis of Helicobacter pylori using the rapid urease test.Ann. Transl. Med.2015319 25705641
     [Google Scholar]
  14. SeufiAM Fast DNA Purification Methods: Comparative Study. WAS Science Nature 202031
     [Google Scholar]
  15. LiJ. ChenS. WangF. Effect of Rosiglitazone, the Peroxisome Proliferator-Activated Receptor (PPAR)-γ Agonist, on Apoptosis, Inflammatory Cytokines and Oxidative Stress in pentylenetetrazole-Induced Seizures in Kindled Mice.Neurochem. Res.2023
     [Google Scholar]
  16. YadegarA. MobarezA.M. AlebouyehM. MirzaeiT. KwokT. ZaliM.R. Clinical relevance of cagL gene and virulence genotypes with disease outcomes in a Helicobacter pylori infected population from Iran.World J. Microbiol. Biotechnol.20143092481249010.1007/s11274‑014‑1673‑5 24854336
     [Google Scholar]
  17. YadegarA. AlebouyehM. ZaliM.R. Analysis of the intactness of Helicobacter pylori cag pathogenicity island in Iranian strains by a new PCR-based strategy and its relationship with virulence genotypes and EPIYA motifs.Infect. Genet. Evol.201535192610.1016/j.meegid.2015.07.026 26205689
     [Google Scholar]
  18. MalekiA. ZamirnastaM. TaherikalaniM. The characterization of bacterial communities of oropharynx microbiota in healthy children by combining culture techniques and sequencing of the 16S rRNA gene.Microb. Pathog.202014310411510.1016/j.micpath.2020.104115 32135220
     [Google Scholar]
  19. HanF. LiuS. HoB. Alterations in rdxA and frxA genes and their upstream regions in metronidazole-resistant Helicobacter pylori isolates.Res. Microbiol.20071581384410.1016/j.resmic.2006.10.001
     [Google Scholar]
  20. HoS.L. TanE.L. SamC.K. GohK.L. Clarithromycin resistance and point mutations in the 23S rRNA gene in Helicobacter pylori isolates from Malaysia.J. Dig. Dis.201011210110510.1111/j.1751‑2980.2010.00423.x 20402836
     [Google Scholar]
  21. ToledoH. López-Solís R. Tetracycline resistance in Chilean clinical isolates of Helicobacter pylori.J. Antimicrob. Chemother.201065347047310.1093/jac/dkp457 20035020
     [Google Scholar]
  22. YingH. MahmudionoT. AlghazaliT. Molecular Characterization, Virulence Determinants, and Antimicrobial Resistance Profile of Methicillin-Resistant Staphylococcus aureus in the North of Iran; a High Prevalence of ST239-SCCmec III/t037 Clone.Chemotherapy2022671374610.1159/000520482 34872086
     [Google Scholar]
  23. WangL.H. ChengH. HuF.L. LiJ. Distribution of gyrA mutations in fluoroquinolone-resistant Helicobacter pylori strains.World J. Gastroenterol.201016182272227710.3748/wjg.v16.i18.2272 20458765
     [Google Scholar]
  24. JustinoM.C. ParenteM.R. BonecaI.G. FrxA is an S‐nitrosoglutathione reductase enzyme that contributes to Helicobacter pylori pathogenicity.FEBS J.2014281194495450510.1111/febs.12958
     [Google Scholar]
  25. MarquesB. DonatoM.M. CardosoO. LuxoC. MartinhoA. AlmeidaN. Study of rdxA and frxA genes mutations in metronidazole-resistant and -susceptible Helicobacter pylori clinical isolates from the central region of Portugal.J. Glob. Antimicrob. Resist.20191730030410.1016/j.jgar.2019.01.008 30658199
     [Google Scholar]
  26. KeikhaM. KarbalaeiM. EPIYA motifs of Helicobacter pylori cagA genotypes and gastrointestinal diseases in the Iranian population: A systematic review and meta-analysis.New Microbes New Infect.20214110086510.1016/j.nmni.2021.100865 33912350
     [Google Scholar]
  27. SavoldiA. CarraraE. GrahamD.Y. ContiM. TacconelliE. Prevalence of antibiotic resistance in Helicobacter pylori: A systematic review and meta-analysis in world health organization regions.Gastroenterology2018155513721382.e1710.1053/j.gastro.2018.07.007 29990487
     [Google Scholar]
  28. AzzayaD GantuyaB OyuntsetsegK High antibiotic resistance of Helicobacter pylori and its associated novel gene mutations among the Mongolian population.20208106210.3390/microorganisms807106
     [Google Scholar]
  29. NaharS. MukhopadhyayA.K. KhanR. Antimicrobial susceptibility of Helicobacter pylori strains isolated in Bangladesh.J. Clin. Microbiol.200442104856485810.1128/JCM.42.10.4856‑4858.2004 15472362
     [Google Scholar]
  30. PandyaH.B. AgravatH.H. PatelJ.S. SodagarN.R.K. Emerging antimicrobial resistance pattern of Helicobacter pylori in central Gujarat.Indian J. Med. Microbiol.201432440841310.4103/0255‑0857.142256 25297026
     [Google Scholar]
  31. SuP. LiY. LiH. Antibiotic resistance of Helicobacter pylori isolated in the southeast coastal region of China.Helicobacter201318427427910.1111/hel.12046 23418857
     [Google Scholar]
  32. Kale-PradhanP.B. MihaescuA. WilhelmS.M. Fluoroquinolone sequential therapy for Helicobacter pylori: A meta‐analysis.Pharmacotherapy201535871973010.1002/phar.1614 26173786
     [Google Scholar]
  33. CattoirV. NectouxJ. LascolsC. Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility.Int. J. Antimicrob. Agents200729438939610.1016/j.ijantimicag.2006.11.007 17303392
     [Google Scholar]
  34. MiyachiH. MikiI. AoyamaN. Primary levofloxacin resistance and gyrA/B mutations among Helicobacter pylori in Japan.Helicobacter2006114243249
     [Google Scholar]
  35. FarziN. YadegarA. SadeghiA. High prevalence of antibiotic resistance in Iranian Helicobacter pylori isolates: Importance of functional and mutational analysis of resistance genes and virulence genotyping.J. Clin. Med.2019811200410.3390/jcm8112004 31744181
     [Google Scholar]
  36. HanafiA. LeeW.C. LokeM.F. Molecular and proteomic analysis of levofloxacin and metronidazole resistant Helicobacter pylori.Front. Microbiol.20167201510.3389/fmicb.2016.02015 28018334
     [Google Scholar]
  37. BogaertsP. BerhinC. NizetH. GlupczynskiY. Prevalence and mechanisms of resistance to fluoroquinolones in Helicobacter pylori strains from patients living in Belgium.Helicobacter200611544144510.1111/j.1523‑5378.2006.00436.x 16961806
     [Google Scholar]
  38. BińkowskaA. BiernatM.M. ŁaczmańskiŁ. Molecular patterns of resistance among Helicobacter pylori strains in south-western Poland.Front. Microbiol.20189315410.3389/fmicb.2018.03154
     [Google Scholar]
  39. De FrancescoV. MargiottaM. ZulloA. Prevalence of primary clarithromycin resistance in Helicobacter pylori strains over a 15 year period in Italy.J. Antimicrob. Chemother.200759478378510.1093/jac/dkm005 17329269
     [Google Scholar]
  40. WueppenhorstN. StuegerH.P. KistM. GlockerE. Identification and molecular characterization of triple- and quadruple-resistant Helicobacter pylori clinical isolates in Germany.J. Antimicrob. Chemother.200963464865310.1093/jac/dkp003 19190100
     [Google Scholar]
  41. KimJ.M. KimJ.S. KimN. Gene mutations of 23S rRNA associated with clarithromycin resistance in Helicobacter pylori strains isolated from Korean patients.J. Microbiol. Biotechnol.200818915841589 18852516
     [Google Scholar]
  42. ThungI AraminH VavinskayaV The global emergence of Helicobacter pylori antibiotic resistance.20164351433
     [Google Scholar]
  43. GerritsM.M. de ZoeteM.R. ArentsN.L.A. KuipersE.J. KustersJ.G. 16S rRNA mutation-mediated tetracycline resistance in Helicobacter pylori.Antimicrob. Agents Chemother.20024692996300010.1128/AAC.46.9.2996‑3000.2002 12183259
     [Google Scholar]
  44. SerikiA.T. SmithS.I. AdeleyeA.I. Molecular analysis of low-level tetracycline resistance in clinical isolates of Helicobacter pylori among dyspeptic patients in south West Nigeria.J. Glob. Antimicrob. Resist.20181314314510.1016/j.jgar.2018.01.003
     [Google Scholar]
  45. TrieberC.A. TaylorD.E. Mutations in the 16S rRNA genes of Helicobacter pylori mediate resistance to tetracycline.J. Bacteriol.200218482131214010.1128/JB.184.8.2131‑2140.2002 11914344
     [Google Scholar]
  46. BoyanovaL. MarkovskaR. YordanovD. GergovaG. MitovI. Clarithromycin Resistance Mutations in Helicobacter pylori in Association with Virulence Factors and Antibiotic Susceptibility of the Strains.Microb. Drug Resist.201622322723210.1089/mdr.2015.0199 26618567
     [Google Scholar]
  47. KarabiberH. SelimogluM.A. OtluB. YildirimO. OzerA. Virulence factors and antibiotic resistance in children with Helicobacter pylori gastritis.J. Pediatr. Gastroenterol. Nutr.201458560861210.1097/MPG.0000000000000273 24792628
     [Google Scholar]
  48. MousaviS. Virulence factors and antibiotic resistance of Helicobacter pylori isolated from raw milk and unpasteurized dairy products in Iran.J. Venom. Anim. Toxins Incl. Trop. Dis.20152051
     [Google Scholar]
  49. van DoornL-J. SchneebergerP. NouhanN. Importance of Helicobacter pylori cagA and vacAstatus for the efficacy of antibiotic treatment.Gut2000463321326
     [Google Scholar]
  50. TaneikeI. NamiA. O’connorA. Analysis of drug resistance and virulence‐factor genotype of Irish Helicobacter pylori strains: is there any relationship between resistance to metronidazole and cagA status?AP&T20093078479010.1111/j.1365‑2036.2009.04095.x
     [Google Scholar]
  51. BachirM. AllemR. TifritA. Primary antibiotic resistance and its relationship with cagA and vacA genes in Helicobacter pylori isolates from Algerian patients.Braz. J. Microbiol.201849354455110.1016/j.bjm.2017.11.003 29452847
     [Google Scholar]
  52. Román-Román A, Martínez-Carrillo DN, Atrisco-Morales J et al. Helicobacter pylori vacA s1m1 genotype but not cagA or babA2 increase the risk of ulcer and gastric cancer in patients from Southern Mexico.Gut Pathog.201791810.1186/s13099‑017‑0167‑z
     [Google Scholar]
  53. Vinagre IDF, Queiroz AL, Silva Júnior MR, Vinagre RMDF, Martins LC. Helicobacter pylori infection in patients with different gastrointestinal diseases from Northern Brazil.Arq. Gastroenterol.201552426627110.1590/S0004‑28032015000400004 26840466
     [Google Scholar]
/content/journals/iddt/10.2174/0118715265294927240617201332
Loading
Molecular Characterization of Antimicrobial Resistance and Virulence Genotyping among Helicobacter pylori-Positive Dyspeptic Patients in North Iran
Infect. Disord. Drug Targets 25, E090724231788 (2025); https://doi.org/10.2174/0118715265294927240617201332
/content/journals/iddt/10.2174/0118715265294927240617201332
/content/journals/iddt/10.2174/0118715265294927240617201332
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): antibiotic resistance; cag pathogenicity; gastric biopsies; Helicobacter pylori; vacuolating cytotoxin; virulence genotyping

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test